Risks for Donors in Uterus Transplantation
Iori Kisu(Fujita Health University), Daisuke Aoki(International University of Health and Welfare), Jun Araki(The University of Tokyo), Kiyoko Umene(Keio University), Nobuhiko Suganuma(Kyoto University), Hisako Hara(The University of Tokyo), Makoto Mihara(The University of Tokyo), Kouji Banno(Keio University)
Cited by 48
Related Papers
Pathological Steps of Cancer-Related Lymphedema: Histological Changes in the Collecting Lymphatic Vessels after Lymphadenectomy
|PLoS ONE|2012|331
Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial
|The Lancet Oncology|2023|214
MicroRNA in Cervical Cancer: OncomiRs and Tumor Suppressor miRs in Diagnosis and Treatment
|The Scientific World JOURNAL|2014|143
Cross‐sectional analysis of germline <i>BRCA</i>1 and <i>BRCA</i>2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer
|Cancer Science|2008|105
Registry of the International Society of Uterus Transplantation: First Report
|Transplantation|2022|100